AI software to guide heart rhythm ablation treatment
Part of Heart & circulation clinical trials.
This study tests new AI software (Volta AF-Xplorer II) that helps doctors guide catheter ablation—a procedure to treat irregular heartbeats like atrial fibrillation. The software may help doctors perform the procedure more effectively and safely in real-world settings.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You need catheter ablation to treat atrial fibrillation or atrial tachycardia (irregular heart rhythms)
- You can be having your first ablation or a repeat procedure
- You are able and willing to give written informed consent
- You do not have a medical reason that would make ablation unsafe for you
- If you live in France, you must be registered with the French social security system
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether an AI software can help doctors identify which people with persistent atrial fibrillation might need more than just a standard ablation procedure. The software analyzes heart signals during the ablation to guide treatment, potentially improving outcomes for people whose condition is more complex.
This trial tests whether an artificial intelligence (AI) system can help choose the best patients for a procedure called catheter ablation for atrial fibrillation (AF). It may improve which people benefit most while keeping safety in mind.
This trial is for people with atrial fibrillation (AF) who are having or recently had a catheter ablation procedure. It looks at how using a special artificial intelligence tool, called VX1, during the procedure affects patient outcomes.
This study tests advanced technology to improve how atrial fibrillation (AFib) is treated with a heart ablation procedure. It may help patients who are already advised to have AFib ablation by seeing how well the approach works in real clinical practice.
This study uses machine learning (computer pattern-finding) to better understand atrial fibrillation and guide care around the time of an ablation procedure. It may help refine how doctors treat certain AF patients based on their heart patterns.
This trial uses an artificial intelligence system (vMap) to find and target abnormal electrical signals outside the pulmonary veins that may be driving atrial fibrillation (AF). The goal is to improve ablation results for people with persistent or recurrent AF.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.